Silencing of the long non-coding RNA NEAT1 suppresses glioma stem-like properties through modulation of the miR-107/CDK6 pathway

Oncology Reports

Volumn 37, Issue 1, 2017, Pages 555-562

  Yang, Xiaoli ^a   Xiao, Zheng ^a   Du, Xiaowei ^a   Huang, Lina ^a   Du, Ganqin ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CDK6; Glioma; Glioma stem cells; miR 107; NEAT1

Indexed keywords

CYCLIN DEPENDENT KINASE 6; LONG UNTRANSLATED RNA; MICRORNA 107; CDK6 PROTEIN, HUMAN; MICRORNA; MIRN107 MICRORNA, HUMAN; NEAT1 LONG NON-CODING RNA, HUMAN; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL SELECTION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE ACTIVATION; GENE SILENCING; GENE TARGETING; GLIOMA CELL LINE; GLIOMA STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEAT1 GENE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CANCER STEM CELL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

AGED; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 6; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASTIC STEM CELLS; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 85006371619     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5266     Document Type: Article

References (39)

1. Khan IS and Ehtesham M: Emerging strategies for the treatment of tumor stem cells in central nervous system malignancies. Adv Exp Med Biol 853: 167-187, 2015.
2. Chien LN, Ostrom QT, Gittleman H, Lin JW, Sloan AE, Barnett GH, Elder JB, McPherson C, Warnick R, Chiang YH, et al: International differences in treatment and clinical outcomes for high grade glioma. PLoS One 10: e0129602, 2015.
3. Mannas JP, Lightner DD, Defrates SR, Pittman T and Villano JL: Long-term treatment with temozolomide in malignant glioma. J Clin Neurosci 21: 121-123, 2014.
4. Perry A and Wesseling P: Histologic classification of gliomas. Handb Clin Neurol 134: 71-95, 2016.
5. Reulen HJ, Poepperl G, Goetz C, Gildehaus FJ, Schmidt M, Tatsch K, Pietsch T, Kraus T and Rachinger W: Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. J Neurosurg 123: 760-770, 2015.
6. Modrek AS, Bayin NS and Placantonakis DG: Brain stem cells as the cell of origin in glioma. World J Stem Cells 6: 43-52, 2014.
7. Dietrich J, Diamond EL and Kesari S: Glioma stem cell signaling: Therapeutic opportunities and challenges. Expert Rev Anticancer Ther 10: 709-722, 2010.
8. Q i P and Du X: The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol 26: 155-165, 2013.
9. Li X, Wu Z, Fu X and Han W: Long noncoding RNAs: Insights from biological features and functions to diseases. Med Res Rev 33: 517-553, 2013.
10. Chen X, Kong J, Ma Z, Gao S and Feng X: Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Am J Cancer Res 5: 2808-2815, 2015.
11. Li Y, Li Y, Chen W, He F, Tan Z, Zheng J, Wang W, Zhao Q and Li J: NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 6: 27641-27650, 2015.
12. He C, Jiang B, Ma J and Li Q: Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS 124: 169-174, 2016.
13. Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 5: 5383, 2014.
14. Blume CJ, Hotz-Wagenblatt A, Hüllein J, Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A, Benner A, et al: p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia 29: 2015-2023, 2015.
15. Wang P, Wu T, Zhou H, Jin Q, He G, Yu H, Xuan L, Wang X, Tian L, Sun Y, et al: Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. J Exp Clin Cancer Res 35: 22, 2016.
16. Liu Q, Sun S, Yu W, Jiang J, Zhuo F, Qiu G, Xu S and Jiang X: Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells. J Neurooncol 122: 283-292, 2015.
17. Wang X, Ma Z, Xiao Z, Liu H, Dou Z, Fengxand Shi H: Chk1 knockdown confers radiosensitization in prostate cancer stem cells. Oncol Rep 28: 2247-2254, 2012.
18. Chen W, Xiao Z, Zhao Y, Huang L and Du G: HIF-1α inhibition sensitizes pituitary adenoma cells to temozolomide by regulating MGMT expression. Oncol Rep 30: 2495-2501, 2013.
19. Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, Liu L, Eyler CE, Heddleston JM, Wu Q, et al: Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis 2: e200, 2011.
20. Dahlrot RH, Hansen S, Jensen SS, Schrøder HD, Hjelmborg J and Kristensen BW: Clinical value of CD133 and nestin in patients with glioma: A population-based study. Int J Clin Exp Pathol 7: 3739-3751, 2014.
21. Clément V, Dutoit V, Marino D, Dietrich PY and Radovanovic I: Limits of CD133 as a marker of glioma self-renewing cells. Int J Cancer 125: 244-248, 2009.
22. Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr and Gillespie GY: CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3: e3655, 2008.
23. Wu J, Lai G, Wan F, Xiao Z, Zeng L, Wang X, Ye F and Lei T: Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells. Tohoku J Exp Med 226: 267-274, 2012.
24. Zhen L, Yun-Hui L, Hong-Yu D, Jun M and Yi-Long Y: Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol 37: 673-683, 2016.
25. Rader J, Russell MR, Hart LS, Nakazawa MS, Belcastro LT, Martinez D, Li Y, Carpenter EL, Attiyeh EF, Diskin SJ, et al: Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma. Clin Cancer Res 19: 6173-6182, 2013.
26. Brzozowska A, Toruń A and Mazurkiewicz M: The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme. Adv Clin Exp Med 24: 279-287, 2015.
27. Jung J, Gilbert MR and Park DM: Isolation and propagation of glioma stem cells from acutely resected tumors. Methods Mol Biol 1516: 361-369, 2016.
28. Codrici E, Enciu AM, Popescu ID, Mihai S and Tanase C: Glioma stem cells and their microenvironments: Providers of challenging therapeutic targets. Stem Cells Int 2016: 5728438, 2016.
29. Liebelt BD, Shingu T, Zhou X, Ren J, Shin SA and Hu J: Glioma stem cells: Signaling, microenvironment, and therapy. Stem Cells Int 2016: 7849890, 2016.
30. Kim SS, Pirollo KF and Chang EH: Isolation and culturing of glioma cancer stem cells. Curr Protoc Cell Biol 67: 23.10.1-23.10.10, 2015. doi: 10.1002/0471143030.cb2310s67.
31. Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA pro?le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 40: 2004-2012, 2012.
32. Sørensen KP, Thomassen M, Tan Q, Bak M, Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers. Breast Cancer Res 17: 55, 2015.
33. Zhang X, Sun S, Pu JK, Tsang AC, Lee D, Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 48: 1-8, 2012.
34. Li R, Qian J, Wang YY, Zhang JX and You YP: Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci Ther 20: 339-343, 2014.
35. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A and Lawrence JB: An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell 33: 717-726, 2009.
36. Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et al: Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene 34: 4546, 2015.
37. You J, Zhang Y, Liu B, Li Y, Fang N, Zu L, Li X and Zhou Q: MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1. Indian J Cancer 51 (Suppl 3): e77-e81, 2014.
38. Campos B and Herold-Mende CC: Insight into the complex regulation of CD133 in glioma. Int J Cancer 128: 501-510, 2011.
39. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z and Fang J: Nestin and CD133: Valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27: 85, 2008.